PQ 66
66. Deputy Clare Daly asked the Minister for Health if access to experimental drugs such as Pembrolizumab will be provided to all women with cervical cancer in view of the decision to make such drugs available to women whose false negative screening results were uncovered during the audit of the CervicalCheck screening programme. [50596/18]
Introduced
5 December 2018
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2018
Summary
66. Deputy Clare Daly asked the Minister for Health if access to experimental drugs such as Pembrolizumab will be provided to all women with cervical cancer in view of the decision to make such drugs available to women whose false negative screening results were uncovered during the audit of the CervicalCheck screening programme. [50596/18]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 5 December 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2018-12-05/66/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2018-12-05/pq_66